1	Two	CD	3	num
2	rival	JJ	3	amod
3	bidders	NNS	7	nsubj
4	for	IN	3	prep
5	Connaught	NNP	6	nn
6	BioSciences	NNPS	4	pobj
7	extended	VBD	0	root
8	their	PRP$	9	poss
9	offers	NNS	7	dobj
10	to	TO	11	aux
11	acquire	VB	9	infmod
12	the	DT	15	det
13	Toronto-based	JJ	15	amod
14	vaccine	NN	15	nn
15	manufacturer	NN	11	dobj
16	Friday	NNP	7	tmod
17	.	.	7	punct

1	Institut	NNP	2	nn
2	Merieux	NNP	3	nn
3	S.A.	NNP	25	nsubj
4	,	,	3	punct
5	which	WDT	6	nsubj
6	offered	VBD	3	rcmod
7	942	CD	8	number
8	million	CD	10	num
9	Canadian	JJ	10	amod
10	dollars	NNS	6	dobj
11	-LRB-	-LRB-	12	punct
12	US$	$	10	dep
13	801.2	CD	12	number
14	million	CD	12	number
15	-RRB-	-RRB-	12	punct
16	,	,	10	punct
17	or	CC	10	cc
18	C$	$	10	conj
19	37	CD	18	num
20	a	DT	21	det
21	share	NN	18	npadvmod
22	for	IN	6	prep
23	Connaught	NNP	22	pobj
24	,	,	3	punct
25	said	VBD	0	root
26	it	PRP	28	nsubj
27	would	MD	28	aux
28	extend	VB	25	ccomp
29	its	PRP$	30	poss
30	bid	NN	28	dobj
31	,	,	30	punct
32	due	JJ	30	amod
33	to	TO	34	aux
34	expire	VB	32	xcomp
35	last	JJ	36	amod
36	Thursday	NNP	34	tmod
37	,	,	30	punct
38	to	TO	28	prep
39	Nov.	NNP	38	pobj
40	6	CD	39	num
41	.	.	25	punct

1	A	DT	4	det
2	C$	$	4	amod
3	30-a-share	JJ	2	dep
4	bid	NN	28	nsubjpass
5	by	IN	4	prep
6	Ciba-Geigy	NNP	7	nn
7	Ltd.	NNP	5	pobj
8	,	,	7	punct
9	a	DT	11	det
10	pharmaceutical	JJ	11	amod
11	company	NN	7	appos
12	based	VBN	11	partmod
13	in	IN	12	prep
14	Basel	NNP	13	pobj
15	,	,	14	punct
16	Switzerland	NNP	14	appos
17	,	,	7	punct
18	and	CC	7	cc
19	California-based	JJ	21	amod
20	Chiron	NNP	21	nn
21	Corp.	NNP	7	conj
22	,	,	21	punct
23	a	DT	25	det
24	bioresearch	NN	25	nn
25	concern	NN	21	appos
26	,	,	21	punct
27	was	VBD	28	auxpass
28	extended	VBN	0	root
29	to	TO	28	prep
30	Nov.	NNP	29	pobj
31	16	CD	30	num
32	.	.	28	punct

1	It	PRP	4	nsubj
2	had	VBD	4	aux
3	been	VBN	4	cop
4	due	JJ	0	root
5	to	TO	6	aux
6	expire	VB	4	xcomp
7	Friday	NNP	8	nn
8	evening	NN	6	tmod
9	.	.	4	punct

1	Merieux	NNP	3	nsubj
2	previously	RB	3	advmod
3	said	VBD	0	root
4	it	PRP	6	nsubj
5	would	MD	6	aux
6	ensure	VB	3	ccomp
7	its	PRP$	8	poss
8	bid	NN	10	nsubj
9	remained	VBD	10	cop
10	open	JJ	6	ccomp
11	pending	VBG	10	prep
12	a	DT	14	det
13	final	JJ	14	amod
14	decision	NN	11	pobj
15	by	IN	14	prep
16	Canadian	JJ	17	amod
17	regulators	NNS	15	pobj
18	on	IN	14	prep
19	whether	IN	21	complm
20	to	TO	21	aux
21	approve	VB	18	pcomp
22	the	DT	23	det
23	takeover	NN	21	dobj
24	.	.	3	punct

1	Merieux	NNP	15	nsubjpass
2	,	,	1	punct
3	a	DT	7	det
4	vaccine	NN	7	nn
5	and	CC	4	cc
6	bioresearch	NN	4	conj
7	firm	NN	1	appos
8	based	VBN	7	partmod
9	in	IN	8	prep
10	Lyon	NNP	9	pobj
11	,	,	10	punct
12	France	NNP	10	appos
13	,	,	1	punct
14	is	VBZ	15	auxpass
15	controlled	VBN	0	root
16	50.1	CD	17	num
17	%	NN	15	npadvmod
18	by	IN	15	prep
19	state-owned	JJ	22	amod
20	Rhone	NNP	21	nn
21	Poulenc	NNP	22	nn
22	S.A	NNP	18	pobj
23	.	.	15	punct

1	The	DT	3	det
2	Canadian	JJ	3	amod
3	government	NN	5	nsubj
4	previously	RB	5	advmod
5	said	VBD	0	root
6	Merieux	NNP	8	poss
7	's	POS	6	possessive
8	bid	NN	11	nsubj
9	did	VBD	11	aux
10	n't	RB	11	neg
11	offer	VB	5	ccomp
12	enough	RB	15	advmod
13	``	``	15	punct
14	net	JJ	15	amod
15	benefit	NN	11	dobj
16	''	''	15	punct
17	to	TO	11	prep
18	Canada	NNP	17	pobj
19	to	TO	21	aux
20	be	VB	21	auxpass
21	approved	VBN	11	xcomp
22	,	,	11	punct
23	and	CC	11	cc
24	gave	VBD	11	conj
25	Merieux	NNP	24	iobj
26	an	DT	24	dobj
27	until	IN	28	dep
28	mid-November	NNP	26	dep
29	to	TO	30	aux
30	submit	VB	24	xcomp
31	additional	JJ	32	amod
32	information	NN	30	dobj
33	.	.	5	punct

1	Merieux	NNP	2	nn
2	officials	NNS	3	nsubj
3	said	VBD	0	root
4	last	JJ	5	amod
5	week	NN	3	tmod
6	that	IN	11	complm
7	they	PRP	11	nsubj
8	are	VBP	11	cop
9	``	``	11	punct
10	highly	RB	11	advmod
11	confident	JJ	3	ccomp
12	''	''	11	punct
13	the	DT	14	det
14	offer	NN	17	nsubjpass
15	will	MD	17	aux
16	be	VB	17	auxpass
17	approved	VBN	11	dep
18	once	IN	20	mark
19	it	PRP	20	nsubj
20	submits	VBZ	17	advcl
21	details	NNS	20	dobj
22	of	IN	21	prep
23	its	PRP$	25	poss
24	proposed	VBN	25	amod
25	investments	NNS	22	pobj
26	to	TO	20	prep
27	federal	JJ	28	amod
28	regulators	NNS	26	pobj
29	.	.	3	punct

1	Both	DT	2	det
2	offers	NNS	4	nsubj
3	are	VBP	4	cop
4	conditional	JJ	0	root
5	on	IN	4	prep
6	regulatory	JJ	7	amod
7	approvals	NNS	5	pobj
8	and	CC	7	cc
9	enough	JJ	10	amod
10	shares	NNS	12	nsubjpass
11	being	VBG	12	auxpass
12	tendered	VBN	7	conj
13	to	TO	14	aux
14	give	VB	12	xcomp
15	the	DT	16	det
16	bidders	NNS	14	iobj
17	a	DT	18	det
18	majority	NN	14	dobj
19	of	IN	18	prep
20	Connaught	NNP	22	poss
21	's	POS	20	possessive
22	shares	NNS	19	pobj
23	outstanding	JJ	22	amod
24	.	.	4	punct

1	Institut	NNP	2	nn
2	Merieux	NNP	14	nsubj
3	,	,	2	punct
4	which	WDT	6	nsubj
5	already	RB	6	advmod
6	holds	VBZ	2	rcmod
7	a	DT	10	det
8	12.5	CD	9	number
9	%	NN	10	amod
10	stake	NN	6	dobj
11	in	IN	10	prep
12	Connaught	NNP	11	pobj
13	,	,	2	punct
14	said	VBD	0	root
15	that	IN	44	complm
16	at	IN	44	prep
17	the	DT	18	det
18	close	NN	16	pobj
19	of	IN	18	prep
20	business	NN	19	pobj
21	Thursday	NNP	44	tmod
22	,	,	44	punct
23	5,745,188	CD	24	num
24	shares	NNS	44	nsubjpass
25	of	IN	24	prep
26	Connaught	NNP	25	pobj
27	and	CC	24	cc
28	C$	$	32	num
29	44.3	CD	28	number
30	million	CD	28	number
31	face	NN	32	nn
32	amount	NN	24	conj
33	of	IN	32	prep
34	debentures	NNS	33	pobj
35	,	,	32	punct
36	convertible	JJ	32	amod
37	into	IN	36	prep
38	1,826,596	CD	40	num
39	common	JJ	40	amod
40	shares	NNS	37	pobj
41	,	,	32	punct
42	had	VBD	44	aux
43	been	VBN	44	auxpass
44	tendered	VBN	14	ccomp
45	to	TO	44	prep
46	its	PRP$	47	poss
47	offer	NN	45	pobj
48	.	.	14	punct

1	At	IN	11	prep
2	the	DT	3	det
3	close	NN	1	pobj
4	of	IN	3	prep
5	business	NN	4	pobj
6	Thursday	NNP	11	tmod
7	,	,	11	punct
8	Ciba-Geigy	NNP	11	nsubj
9	and	CC	8	cc
10	Chiron	NNP	8	conj
11	said	VBD	0	root
12	11,580	CD	14	num
13	common	JJ	14	amod
14	shares	NNS	17	nsubjpass
15	had	VBD	17	aux
16	been	VBN	17	auxpass
17	tendered	VBN	11	ccomp
18	to	TO	17	prep
19	their	PRP$	20	poss
20	offer	NN	18	pobj
21	.	.	11	punct

1	At	IN	6	prep
2	last	JJ	3	amod
3	report	NN	1	pobj
4	,	,	6	punct
5	Connaught	NNP	6	nsubj
6	had	VBD	0	root
7	21.8	CD	8	number
8	million	CD	9	num
9	shares	NNS	6	dobj
10	outstanding	JJ	9	amod
11	.	.	6	punct

1	Separately	RB	7	advmod
2	,	,	7	punct
3	the	DT	6	det
4	Ontario	NNP	6	nn
5	Supreme	NNP	6	nn
6	Court	NNP	7	nsubj
7	said	VBD	0	root
8	it	PRP	10	nsubj
9	will	MD	10	aux
10	postpone	VB	7	ccomp
11	indefinitely	RB	10	advmod
12	a	DT	13	det
13	ruling	NN	10	dobj
14	on	IN	13	prep
15	the	DT	16	det
16	lawsuit	NN	14	pobj
17	launched	VBN	16	partmod
18	by	IN	17	prep
19	the	DT	20	det
20	University	NNP	18	pobj
21	of	IN	20	prep
22	Toronto	NNP	21	pobj
23	against	IN	17	prep
24	Connaught	NNP	23	pobj
25	in	IN	17	prep
26	connection	NN	25	pobj
27	with	IN	26	prep
28	the	DT	30	det
29	Merieux	NNP	30	nn
30	bid	NN	27	pobj
31	.	.	7	punct

1	In	IN	15	prep
2	a	DT	3	det
3	statement	NN	1	pobj
4	prepared	VBN	3	partmod
5	by	IN	4	prep
6	lawyers	NNS	5	pobj
7	for	IN	4	prep
8	the	DT	9	det
9	university	NN	7	pobj
10	and	CC	9	cc
11	Connaught	NNP	9	conj
12	,	,	15	punct
13	the	DT	14	det
14	parties	NNS	15	nsubj
15	said	VBD	0	root
16	they	PRP	17	nsubj
17	agreed	VBD	15	ccomp
18	that	IN	34	complm
19	as	IN	34	prep
20	a	DT	21	det
21	result	NN	19	pobj
22	of	IN	21	prep
23	reaching	VBG	22	pcomp
24	a	DT	29	det
25	C	$	29	num
26	415	CD	25	number
27	million	CD	25	number
28	research	NN	29	nn
29	accord	NN	23	dobj
30	,	,	34	punct
31	``	``	34	punct
32	It	PRP	34	nsubj
33	is	VBZ	34	cop
34	unnecessary	JJ	17	ccomp
35	that	IN	37	complm
36	there	EX	37	expl
37	be	VB	34	ccomp
38	a	DT	39	det
39	judgment	NN	37	nsubj
40	on	IN	39	prep
41	the	DT	42	det
42	merits	NNS	40	pobj
43	-LCB-	-LRB-	42	punct
44	of	IN	42	prep
45	the	DT	46	det
46	case	NN	44	pobj
47	-RCB-	-RRB-	42	punct
48	at	IN	37	prep
49	this	DT	50	det
50	time	NN	48	pobj
51	.	.	15	punct
52	''	''	15	punct

1	Lawyers	NNS	9	nsubj
2	for	IN	1	prep
3	the	DT	5	det
4	two	CD	5	num
5	sides	NNS	2	pobj
6	were	VBD	9	cop
7	n't	RB	9	neg
8	immediately	RB	9	advmod
9	available	JJ	0	root
10	for	IN	9	prep
11	comment	NN	10	pobj
12	.	.	9	punct

1	The	DT	2	det
2	university	NN	4	nsubj
3	had	VBD	4	aux
4	sought	VBN	0	root
5	an	DT	6	det
6	injunction	NN	4	dobj
7	blocking	VBG	6	partmod
8	Connaught	NNP	10	poss
9	's	POS	8	possessive
10	board	NN	7	dobj
11	from	IN	7	prep
12	recommending	VBG	11	pobj
13	or	CC	12	cc
14	supporting	VBG	12	conj
15	an	DT	16	det
16	offer	NN	12	dobj
17	for	IN	16	prep
18	the	DT	19	det
19	company	NN	17	pobj
20	by	IN	16	prep
21	Merieux	NNP	20	pobj
22	.	.	4	punct


